US2021353830A1PendingUtilityA1
Interpenetrating networks with covalent and ionic crosslinks
Est. expiryJan 5, 2032(~5.5 yrs left)· nominal 20-yr term from priority
Inventors:Jeong-Yun SunXuanhe ZhaoWidusha R.K. IlleperumaKyu H. OhJoost J. VlassakZhigang SuoJianyu LiDavid J. Mooney
C08L 2201/54C08L 33/26C08J 3/246C08J 2405/04A61L 27/52C08L 71/02A61L 27/20C08J 2333/26A61L 27/48A61L 27/60C08L 5/04A61L 27/50C08L 2205/04C08J 3/075C08L 2203/02A61L 27/26A61L 27/16
78
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention features a composition comprising a self-healing interpenetrating network hydrogel comprising a first network and a second network. The first network comprises covalent crosslinks and the second network comprises ionic or physical crosslinks. For example, the first network comprises a polyacrylamide polymer and second network comprises an alginate polymer.
Claims
exact text as granted — not AI-modified1 - 36 . (canceled)
37 . A tough interpenetrating networks hydrogel comprising a first network and a second network, wherein:
the first network comprises a covalently crosslinked polymer selected from the group consisting of polyacrylamide, poly(vinyl alcohol), poly(ethylene oxide) and its copolymers, polyethylene glycol (PEG), methacrylated PEG, and polyphosphazene; and the second network comprises an ionically crosslinked polymer selected from the group consisting of alginate, chitosan, and agarose; wherein the first network and the second network are covalently coupled.
38 . The hydrogel of claim 37 , wherein the first network comprises polyacrylamide or polyethylene glycol (PEG) and wherein the second network comprises alginate.
39 . The hydrogel of claim 37 , wherein the first network comprises a covalent crosslinking agent selected from the group consisting of N,N-methylenebisacrylamide (MBAA), a methacrylate crosslinker, N,N′-dicyclohexylcarbodiimide (DCC), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (ECC), N-hydroxysuccinimide, N-hydroxysulfosuccinimide, glutaraldehyde, and a transglutaminase.
40 . The hydrogel of claim 37 , wherein the hydrogel comprises at least 30 wt % water.
41 . The hydrogel of claim 37 , wherein the hydrogel comprises between 30-98 wt % water.
42 . The hydrogel of claim 37 , wherein the hydrogel has a fracture toughness value of at least 10 J/m 2 .
43 . The hydrogel of claim 37 , wherein the hydrogel has a fracture toughness value from 10 J/m 2 to 9000 J/m 2 .
44 . The hydrogel of claim 37 , wherein the hydrogel has a Young's modulus value of at least 10.0 kPa.
45 . The hydrogel of claim 37 , wherein the hydrogel has a Young's modulus value of 10.0 kPa to 300 kPa.
46 . The hydrogel of claim 37 , wherein the hydrogel has a stretch value (λ) of from 2 to 25.
47 . The hydrogel of claim 37 , wherein the hydrogel has a stretch value (λ) of 21.
48 . The hydrogel of claim 37 , wherein the second network comprises an ionic crosslinking agent selected from the group consisting of CaCl 2 , CaSO 4 , CaCO 3 , hyaluronic acid, and polylysine.
49 . A tough interpenetrating networks hydrogel comprising a first network and a second network, wherein:
the first network comprises a covalently crosslinked polymer selected from the group consisting of polyacrylamide, poly(vinyl alcohol), poly(ethylene oxide) and its copolymers, polyethylene glycol (PEG), methacrylated PEG, and polyphosphazene; and the second network comprises an ionically crosslinked polymer selected from the group consisting of alginate, chitosan, and agarose; the hydrogel has a covalently crosslinked polymer/(covalently crosslinked polymer and ionically crosslinked polymer) ratio of between about 66.67 wt. % and 94.12 wt. % based on monomer weights; and wherein the first network and the second network are covalently coupled.
50 . The hydrogel of claim 49 , wherein the first network comprises polyacrylamide or polyethylene glycol (PEG) and wherein the second network comprises alginate.
51 . The hydrogel of claim 49 , wherein the first network comprises a covalent crosslinking agent selected from the group consisting of N,N-methylenebisacrylamide (MBAA), a methacrylate crosslinker, N,N′-dicyclohexylcarbodiimide (DCC), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (ECC), N-hydroxysuccinimide, N-hydroxysulfosuccinimide, glutaraldehyde, and a transglutaminase.
52 . The hydrogel of claim 49 , wherein the second network comprises an ionic crosslinking agent selected from the group consisting of CaCl 2 , CaSO 4 , CaCO 3 , hyaluronic acid, and polylysine.
53 . The hydrogel of claim 49 , wherein the first network comprises a covalent crosslinking agent that is N,N-methylenebisacrylamide (MBAA) and the second network comprises an ionic crosslinking agent that is CaSO 4 .
54 . The hydrogel of claim 49 , wherein the hydrogel has a covalently crosslinked polymer/(covalently crosslinked polymer and ionically crosslinked polymer) ratio of between about 80 wt. % and 92.31 wt. % based on monomer weights.
55 . The hydrogel of claim 49 , wherein the hydrogel has a Young's modulus value of at least 10.0 kPa.
56 . The hydrogel of claim 49 , wherein the hydrogel has a stretch value (λ) of from 2 to 25.Join the waitlist — get patent alerts
Track US2021353830A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.